HIKMA Pharmaceuticals
HIK · London Stock Exchange (primary) / ASE (secondary) · Pharmaceuticals · Pencatatan di AS: HKMPY
Tentang perusahaan
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman in 1978 that has grown into one of the world's leading generic drug manufacturers, with primary listing on the London Stock Exchange. The company manufactures injectables, branded generics, and proprietary drugs sold across the Middle East, North Africa, the US, and Europe. While its primary market is London (HIK LN), it maintains historical and operational roots in Jordan.
| Bursa | London Stock Exchange (primary) / ASE (secondary) |
| Kode saham | HIK |
| Sektor | Pharmaceuticals |
| Pencatatan di AS | HKMPY |
| Kapitalisasi pasar indikatif USD | $4.20B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Diperdagangkan di AS sebagai HKMPY — tersedia melalui sebagian besar akun pialang AS.
Di pasar asal (London Stock Exchange (primary) / ASE (secondary)), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Amman Stock Exchange — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di Jordan
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.